Indian Diabetes Market

The Indian diabetes market size reached USD 5.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.6 Billion by 2034, exhibiting a growth rate (CAGR) of 12.08% during 2026-2034. The growing number of people with unhealthy dietary patterns and adoption of sedentary lifestyles, increasing investments by the Government of India in improving healthcare facilities and producing various novel drugs, and rising construction of hospitals, nursing homes, and clinics represent some of the key factors driving the market.

The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India’s struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

This new report “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

• Focus of the Analysis:
• Historical, current and future prevalence of diabetes in India
• Historical, current and future prevalence of type-1 and type-2 diabetes in India
• Historical, current and future prevalence of diabetes in the urban and rural regions in India
• Historical, current and future prevalence of diabetes among males and females in India
• Historical, current and future prevalence of diabetes among various age groups in India
• Historical, current and future diagnosis rates for diabetes in India
• Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

• Focus of the Analysis:
• Performance of the Oral Antidiabetics market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

• Focus of the Analysis:
• Performance of the Insulin market in India
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the Indian diabetes diagnostics market and its dynamics:

• Focus of the Analysis:
• Performance of the diabetes diagnostics market in India
• Impact of COVID-19
• Performance of key classes
• Performance of key players
• Market outlook

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the Indian diabetes market.

Key Questions Answered in This Report:

• How has the Indian diabetes market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the Indian diabetes market?
• What is the impact of each driver, restraint, and opportunity on the Indian diabetes market?
• What is the breakup of the market based on the segment?
• Which is the most attractive segment in the Indian diabetes market?
• What is the competitive structure of the Indian diabetes market?
• Who are the key players/companies in the Indian diabetes market?

Show more